HempMedsPX Will Enter “CBD Simple” Hemp Cannabidiol (CBD) Concentrate Into Conference’s Cannabis Competition in Traverse City on September 29, 2013
SAN DIEGO, Sept. 24, 2013 (GLOBE NEWSWIRE) — Medical Marijuana Inc. (OTC Pink:MJNA) is pleased to announce to shareholders and the general public that HempMedsPX-a corporate portfolio company of Medical Marijuana Inc. and the exclusive master distributor and contracted marketing company for CannaVest Corp. (OTC:CANV) and Medical Marijuana Inc. – will be attending and submitting product for judging at the Michigan Medical Marijuana Conference on September 29, 2013 in Traverse City, Michigan.
“This is our second MMM Conference, and we couldn’t be more excited,” said Charles Vest, Director of Communications for HempMedsPX and keynote speaker at the conference. “We got a tremendous response to our federally legal CBD-rich hemp oil products at the previous conference in August. The Michigan Court of Appeals ruling that prohibits most edible cannabis products has left an enormous void in the market. Medical cannabis patients who are seeking high-CBD hemp oils and products should know we offer the solution, while allowing them to be in full compliance with state and federal law.”
In addition to exhibiting at the conference, HempMedsPX will be submitting the prototype high-CBD hemp oil concentrate, CBD Simple, for judging at the conference’s “Green Cup.” CBD Simple recently took top CBD honors at the High Times Medical Cannabis Cup in Seattle, Washington.
The Traverse City conference will feature medical cannabis physician certification, medical cannabis patient registration, a legislation panel, classes, industry-related speakers and exhibitors. For more information on the conference Michigan Medical Marijuana Conference, visit their website at MIMedicalMarijuana.com. For more information or to purchase hemp CBD products, please visit HempMedsPX.com or call 866-273-8502.
HempMedsPX offers mainstream marketing, sales, customer service, and logistics for the cannabis industry. HempMedsPX is a corporate portfolio company of Medical Marijuana Inc. (OTC:MJNA) and the exclusive master distributor and contracted marketing company for CannaVest Corp. (OTC:CANV) and Medical Marijuana Inc.. In addition to handling sales and distribution of hemp cannabidiol (CBD) products, HempMedsPX is the communication hub for the Medical Marijuana Inc. family of companies.
About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value. For more information, please visit the company’s website at: www.MedicalMarijuanaInc.com
About CannaVest Corp.
CannaVest Corp. (OTC:CANV) is in the business of investing and developing hemp-based cannabinoid companies. CannaVest Corp. also develops, produces, markets and sells end-consumer products to the nutraceutical industry containing the hemp plant extract, cannabidiol (CBD). Additionally, the company resells-to third parties-raw product acquired by CannaVest Corp. pursuant to the company’s supply relationships in Europe. CannaVest Corp. seeks to take advantage of an emerging worldwide trend to re-energize the production of industrial hemp and to foster its many uses for consumers. Cannabinoids (cannabidiol/CBD) are natural constituents of the hemp plant and CBD is derived from hemp stalk and seed. Additional information is available from OTCMarkets.com or by visiting CannaVest.com.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. and CannaVest Corp. to be materially different from the statements made herein.
Medical Marijuana, Inc., CannaVest Corp., and HempMedsPX do not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell and distribute hemp-based products and are involved with Federally Legal Distribution of Medical Marijuana based products within certain international markets.
Investor relations contact:
Stuart T. Smith